Proehl Gerald T
- SEC CIK
- 0001279191
No open-market purchases or sales filed in the past year.
Current role at each company
- DRMA Dermata Therapeutics, Inc.PRESIDENT, CHAIRMAN, CEOas of Aug 18, 2026
- TENX Tenax Therapeutics, Inc.Directoras of Jan 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Proehl Gerald T as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TENX Tenax Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2024 (view filing) | Aug 8 | Same day | Proehl Gerald TDirector | PPurchase | +1.67K | – | – | +166,600.0%1.67K after | |
| Aug 8, 2024 (view filing) | Aug 8 | Same day | Proehl Gerald TDirector | PPurchase | +48.3K | – | – | –16.7K after | Derivative2 lots |
DRMA Dermata Therapeutics, Inc.
PRESIDENT, CHAIRMAN, CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 (view filing) | Aug 16-17 | 1 day | Proehl Gerald TPresident, CEO and Chairman | PPurchase | +152.9K | $4.96 | +$49.6K | New position152.9K after | 2 lots |
| Aug 17, 2021 (view filing) | Aug 17 | Same day | Proehl Gerald TPresident, CEO and Chairman | PPurchase | +142.9K | – | – | –142.9K after | Derivative |
| Nov 26, 2021 (view filing) | Nov 23 | 3 days | Proehl Gerald TPresident, CEO and Chairman | PPurchase | +20.0K | $2.40 | +$48.0K | +50.6%59.5K after |